Panagora Asset Management’s Solid Biosciences SLDB Stock Holding History

Panagora Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$656K	Sell	91,095 -135,660	-60%	-$872K	﹤0.01%	798
2025 Q4	$1.28M	Sell	226,755 -170,433	-43%	-$924K	﹤0.01%	651
2025 Q3	$2.45M	Buy	+397,188	New	+$2.32M	0.01%	479
2022 Q1	–	Sell	-8,120	Closed	-$213K	–	1590
2021 Q4	$213K	Buy	8,120 +138	+2%	+$4.22K	﹤0.01%	1474
2021 Q3	$286K	Buy	7,982 +7,934	+16,529%	+$337K	﹤0.01%	1533
2021 Q2	$3K	Sell	48 -49	-51%	-$3.24K	﹤0.01%	2588
2021 Q1	$8K	Hold	97	–	–	﹤0.01%	2468
2020 Q4	$11K	Buy	97 +49	+102%	+$3.1K	﹤0.01%	2282
2020 Q3	$1K	Buy	+48	New	+$1.84K	﹤0.01%	2659
2020 Q2	–	Sell	-992	Closed	-$36K	–	2646
2020 Q1	$36K	Buy	+992	New	+$49.1K	﹤0.01%	1962

Other funds holding SLDB

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Panagora Asset Management's SLDB Position: Q1 2026 in Review

Panagora Asset Management reduced its Solid Biosciences (SLDB) stake by 60% in Q1 2026, selling an estimated $872K and leaving 91,095 shares worth $656K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Panagora Asset Management first reported a position in SLDB in Q1 2020 and has held it in 10 quarters since. The position peaked at $2.45M in Q3 2025. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

Panagora Asset Management held 91,095 shares of Solid Biosciences worth $656K as of Q1 2026.
Panagora Asset Management sold 135,660 Solid Biosciences shares in Q1 2026, an estimated $872K.
Solid Biosciences made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #798 holding.
Panagora Asset Management first reported a position in Solid Biosciences in Q1 2020 and has held it in 10 quarters since.
Panagora Asset Management's Solid Biosciences position peaked at $2.45M in Q3 2025.
150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.